Abstract：Objective To investigate the efficacy of probiotics in adjuvant treatment of non-alcoholic fatty liver disease(NAFLD).Methods Seventy-two patients diagnosed with NAFLD in Fujian Provincial Hospital from January 2018 to December 2019 were selected as subjects.They were divided into observation group(n=36)and control group(n=36)by random number table method.The control group was treated with conventional symptomatic treatment,and the observation group was treated with conventional symptomatic treatment plus oral intestinal probiotics.Alanine aminotransferase(ALT),aspartate aminotransferase(AST),γ -glutamyl transpeptidase(GGT),total bilirubin(TBil),total cholesterol(TC),triacylglycerol(TG),tumor necrosis factor-α(TNF-α)and body mass index(BMI)were compared between the two groups before and after treatment.Results After treatment,ALT,AST,GGT,TBil,TC,TG,TNF-α and BMI in the two groups were lower than those before treatment,the differences were statistically significant(P<0.05).After treatment,ALT,AST,GGT,TC and TG in observation group were lower than those in control group,the differences were statistically significant(P<0.05).There were no significant differences in TBil,TNF-α and BMI between the two groups(P>0.05).Conclusion Taking proper amount of probiotics has a certain positive effect on adjuvant treatment of NAFLD.
Cui Y，Wang Q，Chang R，et al.Intestinal barrier function-nonalcoholic fatty liver disease interactions and possible role of gut microbiota[J].J Agric Food Chem，2019，67（10）：2754-2762.
[8]
Jasirwan COM，Lesmana CRA，Hasan I，et al.The role of gut microbiota in non-alcoholic fatty liver disease：pathways of mechanisms[J].Biosci Microbiota Food Health，2019，38（3）：81-88.
Liu L，Li P，Liu Y，et al.Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease：A Meta-Analysis[J].Dig Dis Sci，2019，64（12）：3402-3412.
京公网安备 11010502046607号